tiprankstipranks
Trending News
More News >
Strata Skin Sciences Inc (SSKN)
NASDAQ:SSKN
US Market

Strata Skin Sciences (SSKN) Earnings Dates, Call Summary & Reports

Compare
197 Followers

Earnings Data

Report Date
Aug 19, 2025
TBA Not Confirmed
Period Ending
2025 (Q2)
Consensus EPS Forecast
-0.29
Last Year’s EPS
0.53
Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings

Earnings Call Summary

Earnings Call Date:May 14, 2025
|
% Change Since: -1.89%
|
Next Earnings Date:Aug 19, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a generally positive sentiment with multiple areas of growth, including international sales, TheraClearX device expansion, and improved margins. However, these were partially offset by concerns over stagnant total revenue growth, potential tariff impacts, and challenges in domestic recurring billings.
Company Guidance
During the first quarter of 2025, STRATA Skin Sciences reported strong progress in its turnaround strategy, which focuses on increasing recurring revenue per device and optimizing device utilization. The company achieved over 1,000 patient appointments, marking a 33% increase in unique patients with insurance benefits handled compared to Q1 2024. STRATA's Elevate 360 consulting program facilitated higher patient conversion and improved clinic operations, leading to increased demand and device usage. The company's domestic installed base of approximately 850 devices showed a fourth consecutive quarter of year-over-year growth in average net recurring revenue. Internationally, sales rose 8% to $2.5 million, with equipment sales up 13% and recurring treatment revenue up 27%, despite a 5% decline in parts and maintenance. The TheraClearX device also experienced growth, with an installed base reaching 160 devices and a 138% increase in patients submitted for reimbursement in Q1 2025 compared to the previous year. Overall, STRATA's strategic initiatives have resulted in improved margins and controlled operating expenses, with a gross margin of 53.5% and a 5% reduction in total operating expenses year-over-year.
Growth in Direct-to-Consumer Marketing Efforts
The company's Direct-to-Consumer marketing efforts have achieved increased XTRAC leads, resulting in more robust patient appointments volume and higher device utilization.
Elevation in Recurring Revenue
STRATA Skin Sciences reported growth in recurring revenue per device across its domestic installed base of approximately 850 devices, marking the fourth consecutive quarter of year-over-year growth.
TheraClearX Device Expansion
The installed base of TheraClearX devices in the US increased to 160 from 104, and the number of patients submitted for reimbursement in Q1 2025 showed a 138% increase over the previous year.
International Business Growth
International sales reached $2.5 million, up 8% from the previous year, with equipment sales up 13% and recurring treatments revenue up 27%.
Improved Gross Margin
Gross margin improved to 53.5% in Q1 2025 from 45.6% in the same period in 2024, driven by efficiency gains and the absence of a one-time inventory write-off.
Reduction in Operating Expenses
Total operating expenses for Q1 2025 were reduced by 5% compared to the previous year, due to reductions in engineering, product development, and selling expenses.

Strata Skin Sciences (SSKN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SSKN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 19, 2025
2025 (Q2)
-0.29 / -
0.533
May 14, 2025
2025 (Q1)
-0.52 / -0.23
-0.43247.22% (+0.20)
Mar 27, 2025
2024 (Q4)
-0.30 / -0.86
-0.416-107.93% (-0.45)
Nov 13, 2024
2024 (Q3)
-0.45 / -0.19
0.397-148.36% (-0.59)
Aug 14, 2024
2024 (Q2)
-0.70 / 0.53
-0.0252232.00% (+0.56)
May 15, 2024
2024 (Q1)
-0.65 / -0.43
-0.205-110.73% (-0.23)
Mar 27, 2024
2023 (Q4)
-0.20 / -0.42
0.45-192.44% (-0.87)
Nov 14, 2023
2023 (Q3)
-0.40 / 0.40
-0.3232.33% (+0.70)
Aug 09, 2023
2023 (Q2)
-0.55 / -0.03
-0.46894.66% (+0.44)
May 15, 2023
2023 (Q1)
- / -
-0.669
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SSKN Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 14, 2025
$2.64$2.68+1.52%
Mar 27, 2025
$2.71$2.69-0.74%
Nov 13, 2024
$3.35$3.10-7.46%
Aug 14, 2024
$2.79$2.77-0.72%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Strata Skin Sciences Inc (SSKN) report earnings?
Strata Skin Sciences Inc (SSKN) is schdueled to report earning on Aug 19, 2025, TBA Not Confirmed.
    What is Strata Skin Sciences Inc (SSKN) earnings time?
    Strata Skin Sciences Inc (SSKN) earnings time is at Aug 19, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is SSKN EPS forecast?
          SSKN EPS forecast for the fiscal quarter 2025 (Q2) is -0.29.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis